Corporate News     29-May-24 Board of RHI Magnesita India recommends final dividend Of Rs 2.5 per share RHI Magnesita India announced that the Board of Directors of the Company at its meeting held on 29 May 2024, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 250%) , subject to the approval of the shareholders. Previous News   RHI Magnesita India consolidated net profit rises 20.72% in the December 2024 quarter  ( Results - Announcements 12-Feb-25   07:39 )   RHI Magnesita India consolidated net profit rises 67.59% in the September 2022 quarter  ( Results - Announcements 10-Nov-22   07:59 )   RHI Magnesita to acquire Indian refractory biz of Dalmia Bharat Refractories  ( Corporate News - 06-Jan-23   09:45 )   RHI Magnesita India to hold board meeting  ( Corporate News - 08-May-24   17:01 )   Orient Refractories consolidated net profit declines 20.61% in the September 2020 quarter  ( Results - Announcements 03-Nov-20   17:03 )   Board of RHI Magnesita India recommends final dividend  ( Corporate News - 28-May-22   16:43 )   Orient Refractories director resigns  ( Corporate News - 31-Dec-19   13:06 )   Orient Refractories standalone net profit rises 30.97% in the December 2017 quarter  ( Results - Announcements 13-Feb-18   09:26 )   Volumes soar at General Insurance Corporation of India counter  ( Hot Pursuit - 16-Mar-22   11:00 )   Orient Refractories to conduct board meeting  ( Corporate News - 09-Jun-21   09:40 )   Orient Refractories standalone net profit rises 13.37% in the December 2015 quarter  ( Results - Announcements 05-Feb-16   18:03 )	Other Stories   Board of HCL Technologies recommends Interim Dividend   14-Jul-25   17:52   Objectone Information Systems to conduct board meeting   14-Jul-25   17:50   JTEKT India AGM scheduled   14-Jul-25   17:50   Setco Automotive to discuss results   14-Jul-25   17:50   Saurashtra Cement to hold board meeting   14-Jul-25   17:49   John Cockerill India to table results   14-Jul-25   17:49   ATV Projects India to conduct board meeting   14-Jul-25   17:49   Shilchar Technologies schedules AGM   14-Jul-25   17:49   Sun Pharma settles litigation related to LEQSELVI™ with Incyte   14-Jul-25   16:53   Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States   14-Jul-25   16:48
Back Top